Brewin Dolphin LTD Bristol Myers Squibb CO Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brewin Dolphin LTD holds 13,767 shares of BMY stock, worth $795,181. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,767
Previous 15,797 12.85%
Holding current value
$795,181
Previous $1.15 Million 8.15%
% of portfolio
0.05%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 14, 2022
SELL
$72.62 - $79.98 $147,418 - $162,359
-2,030 Reduced 12.85%
13,767 $1.06 Million
Q1 2022

Nov 14, 2022
SELL
$61.48 - $73.72 $8,853 - $10,615
-144 Reduced 0.9%
15,797 $1.15 Million
Q4 2021

Nov 14, 2022
BUY
$53.63 - $62.52 $854,915 - $996,631
15,941 New
15,941 $994,000
Q2 2021

Nov 09, 2023
SELL
$61.91 - $67.42 $18,573 - $20,226
-300 Reduced 1.27%
23,276 $1.56 Billion
Q1 2021

Nov 09, 2023
SELL
$59.34 - $66.74 $95,596 - $107,518
-1,611 Reduced 6.4%
23,576 $1.49 Billion
Q4 2020

Nov 09, 2023
SELL
$57.74 - $65.43 $5,774 - $6,543
-100 Reduced 0.4%
25,187 $1.56 Billion
Q3 2020

Nov 09, 2023
SELL
$57.43 - $63.64 $11,486 - $12,728
-200 Reduced 0.78%
25,287 $1.52 Billion
Q2 2020

Nov 09, 2023
BUY
$54.82 - $64.09 $418,002 - $488,686
7,625 Added 42.69%
25,487 $1.5 Billion
Q1 2020

Nov 09, 2023
SELL
$46.4 - $67.43 $10,254 - $14,902
-221 Reduced 1.22%
17,862 $996 Million
Q4 2019

Nov 09, 2023
BUY
$49.21 - $64.19 $140,937 - $183,840
2,864 Added 18.82%
18,083 $1.16 Billion
Q3 2019

Nov 09, 2023
BUY
$42.77 - $50.71 $11,120 - $13,184
260 Added 1.74%
15,219 $772 Million
Q2 2019

Nov 09, 2023
SELL
$44.62 - $49.34 $126,810 - $140,224
-2,842 Reduced 15.97%
14,959 $678 Million
Q1 2019

Nov 09, 2023
SELL
$45.12 - $53.8 $36,231 - $43,201
-803 Reduced 4.32%
17,801 $849 Million
Q4 2018

Nov 09, 2023
SELL
$48.76 - $63.23 $307,431 - $398,665
-6,305 Reduced 25.31%
18,604 $967 Million
Q3 2018

Nov 09, 2023
SELL
$55.19 - $62.25 $54,638 - $61,627
-990 Reduced 3.82%
24,909 $1.55 Billion
Q2 2018

Nov 09, 2023
SELL
$50.53 - $62.98 $119,553 - $149,010
-2,366 Reduced 8.37%
25,899 $1.43 Billion
Q1 2018

Nov 09, 2023
BUY
$59.92 - $68.98 $96,471 - $111,057
1,610 Added 6.04%
28,265 $1.79 Billion
Q4 2017

Nov 09, 2023
SELL
$59.94 - $65.35 $11,388 - $12,416
-190 Reduced 0.71%
26,655 $1.63 Billion
Q3 2017

Nov 09, 2023
BUY
$55.23 - $63.74 $722,297 - $833,591
13,078
26,845 $1.71 Billion

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email